The school year has a certain rhythm to it with discernible mile markers along the way. Holidays, the beginning and end of sports seasons, concerts, progress reports, theater productions, the end of a quarter or semester, prom, graduation for seniors, Q5 for underclassmen, etc. Countless stops, both large and small, greet us along our school-year journey. We have a few signature events; none of which are bigger, or more important, than Kicks for Cancer. It is a true community-wide event with contributions, both large and small, from hundreds of individuals.
Soccer coach and integral part of the Kicks-for-Cancer Team, Ray Pavlik added this about KFC: "This has turned into an amazing community event that would not be possible without the efforts of the hundreds of volunteers who helped chaperone the dance, man the ticket and information booths and cheer on the runners. Whether you danced, cheered, played, ran or volunteered, you made a difference." Assistant Coach Steve Wells marveled at what at KFC has become. "It is such an amazing event that brings the community together for a great cause."
The 2018 rendition was historic on several levels. Starting with the Pink Dance on Friday night, Sticks for Cancer and Kicks for Cancer on Saturday, and the newly added Mighty Moose 5K on Sunday, (Mighty Moose Video) we raised over 115,000 dollars to help support ovarian research at Dana Farber under the direction of Dr. Ursula Matulonis.
It is amazing to think the money we raised will be used to help with a new early detection system that is hoping to move forward and gain FDA approval. Our Contributions will help to speed up that process, and potentially save lives.
Meri-Sue Nuzum, Chairperson for KFC, had this to say about Kicks. "I am sending out this simple, deeply heartfelt thank you to ALL the volunteers, teams, and supporters of Kicks for Cancer 2018. The 12th annual KFC was an amazing weekend of fantastic weather, incredible sporting events, joyous celebrations of life and awe-inspiring tributes to those we love who battle cancer. It was an extraordinary community event."
Below I include detailed information about Dr. Ursula Matulonis and more about the research under her direction along with two Boston Globe articles honoring Jenna Swaim and Ash Baird.
Dr. Ursula Matulonis Bio
Ursula A. Matulonis, MD is Chief, Division of Gynecologic Oncology at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. Her research focuses on targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how that can lead to rationale targeted drug selection. Dr. Matulonis is the Principal Investigator of several clinical trials and translational studies for ovarian cancer. Dr. Matulonis is a Co-PI on an ovarian cancer SPORE project entitled “Identification of Oncogenic Mutations in Ovarian Cancer,” and a Co-PI on the project “Genetic relationships between breast and ovarian cancer” that is funded by the Breast Cancer Research Foundation. She is also a past recipient of a DF/HCC Ovarian Cancer SPORE Developmental Grant entitled “Genetic Fingerprinting of Ovarian Cancer.”
Dr. Matulonis serves on the National Comprehensive Cancer Network Ovarian Cancer Recommendation and Guideline Committee for both ovarian cancer and for the treatment of anemia, the Gynecologic Oncology Group Quality of Life Committee, a member of The Cancer Genome Atlas Project (TCGA) Endometrial Analysis Working Group, and is Medical Director and Board Member for the non-profit organization Ovations for the Cure. She is a recipient of the Dennis Thompson Compassionate Care Scholar award, the Lee Nadler “Extra Mile” Award, and was named one of Boston’s Best Physicians in Medical Oncology by Boston Magazine numerous times. She serves on the editorial board of the Journal of Clinical Oncology.
After receiving her MD from Albany Medical College, she completed an internship and residency at the University of Pittsburgh, followed by a medical oncology fellowship at Dana-Farber.
Clinical Trials in Gynecologic Malignancies
The Medical Gynecologic Oncology Program serves as the infrastructure for clinical and translational research at Dana-Farber Cancer Institute. Our research involves testing novel drugs and biologics in newly diagnosed as well as recurrent gynecologic tumors: ovarian, endometrial, cervical, vaginal, and vulvar cancers. A list of ongoing clinical trials is available via our website. Our integrated team of medical oncologists, gynecologic oncology surgeons, radiation oncologists, gynecologic oncology pathologists, clinical research team, and basic science researchers are immersed in a number of translational projects. Examples of ongoing projects include the expression profiling and genotyping of ovarian cancer and the study of circulating tumor cells in ovarian cancer.
Thank you to the Kicks for Cancer sponsors who so generously gave for a great cause.
CCHS Trip Presentation Evening Reminder
By Laurie Fortunato
Families and students are invited to the annual CCHS Trip Presentation tonight, Wednesday, October 10th, from 6-7:00pm in the Learning Commons. This event will showcase all of the trips that CCHS teachers are offering in the coming year as well as some running next year. We hope you will join us to learn about the exciting opportunities for students and gather information to help with your planning.
We assembled a fantastic student-led PR team that aims to cover all things CCHS. Their first assignment was Kicks for Cancer, and I include a few of their videos below. CCHS students Ellen Su, Grace Jennings, Ted Sweeney, and Gabby Shih make a fantastic team, and we look forward to showcasing their coverage throughout the year. In addition to the videos below, I have included some pictures they snapped while covering engineering and biology labs and CCHS senior Ravin Nanda making music.
The best opportunity to see their work is to follow us on Instagram and Facebook.
Kicks for Cancer Video Via Instagram
Kicks for Cancer Video Via Facebook
More Kicks for Cancer Video Clips
No comments:
Post a Comment